We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Crowd-Sourced RNA Designs Outclass Computer Algorithms

By LabMedica International staff writers
Posted on 05 Feb 2014
An energetic group of nonexperts, working through an online interface and receiving feedback from lab experiments, has generated RNA (ribonucleic acid) molecule designs that are consistently more effective than those generated by the best computerized design algorithms.

Moreover, the researchers collected some of the best design rules and practices generated by players of the online EteRNA design challenge, and employing machine learning principles, generated their own automated design algorithm, EteRNABot, which also outperform earlier design algorithms. More...
Although this optimized computer design application is faster than humans, the designs it generates still do not match the quality of those of the online community, which now has more than 130,000 members.

The research was published January 27, 2014, in the Proceedings of the National Academy of Sciences of the United States of America (PNAS) online early edition. “The quality of the designs produced by the online EteRNA community is just amazing and far beyond what any of us anticipated when we began this project three years ago,” said Dr. Adrien Treiulle, an assistant professor of computer science and robotics at Carnegie Mellon University (Pittsburgh, PA, USA), who leads the project with Dr. Rhiju Das, an assistant professor of biochemistry at Stanford University (Stanford, CA, USA; www.stanford.edu), and Jeehyung Lee, a PhD student in computer science at Carnegie Mellon.

“This wouldn’t be possible if EteRNA members were just spitting out designs using online simulation tools,” Dr. Treuille continued. “By actually synthesizing the most promising designs in Das’ lab at Stanford, we’re giving our community feedback about what works and doesn’t work in the physical world. And, as a result, these nonexperts are providing us insight into RNA design that is significantly advancing the science.”

RNA is one of the three macromolecules vital for life, along with DNA and proteins. Long recognized as a messenger for genetic data, RNA also may play a much larger role as a regulator of cells. Understanding RNA design could be helpful for treating or controlling diseases such as HIV, for creating RNA-based sensors or even for building computers out of RNA.

The researchers, in the project, assessed the performance of the EteRNA community, EteRNABot and two cutting-edge RNA design algorithms in generating designs that would cause RNA strands to fold themselves into specific shapes. The computers could generate designs in less than one minute, while most people would take one or two days; synthesizing the molecules to determine the success and quality took a month for each design, so the entire experiment lasted about a year.

Ultimately, Dr. Lee reported, the designs produced by humans had a 99% likelihood of being superior to those of the earlier computer algorithms, whereas EteRNABot produced designs with a 95% probability of outdoing the earlier algorithms. “The quality of the community’s designs is so good that even if you generated thousands of designs with computer algorithms, you’d never find one as good as the community’s,” Mr. Lee said.

When the project began, players were asked to design RNA that folded into specific shapes selected by the Das lab. Due to technologic advances that now enable Dr. Das and his team to synthesize 1,000 design sequences monthly instead of the original 30, EteRNA has become an open research project to which researchers from labs around the world can submit design challenges.

Even though EteRNA players may not be scientifically trained, they nonetheless have instincts that, when reinforced by the lab experiments, can lead to new insights. “Most players didn’t have tactical insights on RNA designs,” Mr. Lee said. “They would just recognize patterns—visual patterns. Scientifically, not all of these rules initially seemed to make sense, but people who were following them did better.”

One design rule generated by the players involves “capping.” RNA consists of long sequences of pairs of nucleotides and typically the simplest way to create a sequence or “stack” that will not tear itself apart when synthesized is to fill it with guanine-cytosine (GC) pairs. However, too many GC pairs can generate some unforeseen shapes when synthesized, “It’s like doing origami with a cardboard box,” as one player noted.

According to Mr. Lee, the players found a solution by putting the GC pairs only at the end of the stack—capping—and filling the rest of the stack with adenine-uracil pairs. The investigators are now looking at expanding its design regimen to include three-dimensional (3D) designs. They also are developing a template that researchers in other fields can use to convert scientific projects into online challenges.

Related Links:

Carnegie Mellon University
Stanford University
EteRNA design challenge



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.